This series is coordinated by Christopher W
Certain GLP-1 formulations have demonstrated cardiovascular benefits in clinical trials, leading to specific FDA approvals: Victoza, Ozempic, and Trulicity are approved for reducing major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease, while Wegovy is approved for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight
Some insurance plans cover Zepbound for weight loss with prior authorization, while others exclude weight loss medications as a benefit category
GLP-1: GLP-1 + GIP: All plans include consultation, medication, injection kit, free shipping, and 24/7 support
For example, lean chow-fed Glp1r cell/ :Gcgr cell/ mice exhibit normal oral and IP glucose tolerance as compared to wild-type controls